Cargando…

Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19

Virus induced endothelial dysregulation is a well-recognised feature of severe Covid-19 infection. Endothelin-1 (ET-1) is the most highly expressed peptide in endothelial cells and a potent vasoconstrictor, thus representing a potential therapeutic target. ET-1 plasma levels were measured in a cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, George R., Kuc, Rhoda E., Althage, Magnus, Greasley, Peter J., Ambery, Philip, Maguire, Janet J., Wilkinson, Ian B., Hoole, Stephen P., Cheriyan, Joseph, Davenport, Anthony P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941861/ https://www.ncbi.nlm.nih.gov/pubmed/35339512 http://dx.doi.org/10.1016/j.yjmcc.2022.03.007

Ejemplares similares

Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention
por: Abraham, George R., et al.
Publicado: (2022)

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19
por: Fisk, Marie, et al.
Publicado: (2021)

Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
por: Kuc, Rhoda E., et al.
Publicado: (2014)

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study
por: Abraham, George R., et al.
Publicado: (2022)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

In vitro metabolism of synthetic Elabela/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA
por: Nyimanu, Duuamene, et al.
Publicado: (2021)

Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
por: Owen, Nicola E., et al.
Publicado: (2021)

The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro
por: Maguire, Janet J., et al.
Publicado: (2014)

Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
por: Williams, Thomas L., et al.
Publicado: (2023)

Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12
por: Maguire, J J, et al.
Publicado: (2014)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling
por: Miller, Eileen, et al.
Publicado: (2017)

Cardiac action of the first G protein biased small molecule apelin agonist
por: Read, Cai, et al.
Publicado: (2016)

Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor
por: Maguire, Janet J., et al.
Publicado: (2011)

Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature
por: Kennedy, Amanda J., et al.
Publicado: (2016)

Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022)

Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
por: Brame, Aimee L., et al.
Publicado: (2015)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021)

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
por: Ford, Thomas J, et al.
Publicado: (2020)

Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes
por: Macrae, Robyn G C, et al.
Publicado: (2022)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Plasma endothelin-1 and single nucleotide polymorphisms of endothelin-1 and endothelin type A receptor genes as risk factors for normal tension glaucoma
por: Kosior-Jarecka, Ewa, et al.
Publicado: (2016)

Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
por: Yang, Peiran, et al.
Publicado: (2017)

Hepatic and Plasma Endothelin‐1 in Dogs with Chronic Hepatitis
por: Sakamoto, Y., et al.
Publicado: (2017)

Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015)

Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
por: Yang, Peiran, et al.
Publicado: (2015)

Expert opinion on the management of pain in hospitalised older patients with cognitive impairment: a mixed methods analysis of a national survey
por: Rodger, Kirsty TM, et al.
Publicado: (2015)

Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014)

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
por: Williams, Thomas L., et al.
Publicado: (2021)

Low levels of plasma endothelin-1 in patients with retinitis pigmentosa
por: Ohguro, Hiroshi, et al.
Publicado: (2010)

Changes of the Plasma Endothelin in Adaptation to Increased Salt Intake in Rats
por: Oh, Hyun-Sook, et al.
Publicado: (1997)

The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect of the endothelin A receptor antagonist zibotentan
por: Veenit, Vandana, et al.
Publicado: (2023)

Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)

Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects
por: Muratli, Hasan Hilmi, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_bo5reg1r44aivcnnkgp8llieg0